RESUMEN
¼ Identification of malnourished and at-risk patients should be a standardized part of the preoperative evaluation process for every patient.¼ Malnourishment is defined as a disorder of energy, protein, and nutrients based on the presence of insufficient energy intake, weight loss, muscle atrophy, loss of subcutaneous fat, localized or generalized fluid accumulation, or diminished functional status.¼ Malnutrition has been associated with worse outcomes postoperatively across a variety of orthopaedic procedures because malnourished patients do not have a robust metabolic reserve available for recovery after surgery.¼ Screening assessment and basic laboratory studies may indicate patients' nutritional risk; however, laboratory values are often not specific for malnutrition, necessitating the use of prognostic screening tools.¼ Nutrition consultation and perioperative supplementation with amino acids and micronutrients are 2 readily available interventions that orthopaedic surgeons can select for malnourished patients.
Asunto(s)
Desnutrición , Procedimientos Ortopédicos , Ortopedia , Humanos , Estado Nutricional , Procedimientos Ortopédicos/efectos adversos , Suplementos DietéticosRESUMEN
BACKGROUND CONTEXT: Previous studies documenting the osteoconductive nature of calcium sulfate (CaSO(4))-based biomaterials have been largely limited to animal models exhibiting nonosteoporotic bone biology. In addition to diminished bone mineral density (BMD) and altered bone microarchitecture, the osteoporosis phenotype is associated with a proinflammatory and pro-osteolytic state. Thus, osteoporosis may elicit an amplified bioreactivity to common orthopedic biomaterials, potentially limiting their full osteoconductive capabilities in vivo. PURPOSE: The purpose of this study is to test the hypothesis that CaSO(4)-based bone cements exhibit altered bioreactivity and limited osteoconductivity in response to osteoporotic conditions. STUDY DESIGN: 1) Microcomputed tomography (micro-CT) radiomorphometry study and 2) histological analysis. METHODS: Our laboratory has previously established a preclinical model of osteoporosis using the rodent osteoporotic spine (OS). Caudal vertebral defects were filled with either CaSO(4) or CaSO(4)/CaPO(4) (Hybrid) cement for each group (n=4). Over 8 weeks, cement resorption profiles, BMD, average cortical thickness, average trabecular thickness, average trabecular spacing, and diaphyseal bone volume fraction were assessed via micro-CT radiomorphometry. Histological analysis was performed on vertebrae obtained postsurgery and at Week 8. RESULTS: Both materials displayed an accelerated cement resorption profile after implantation into the OS vertebrae. Hybrid cement exhibited slower resorption compared with that of CaSO(4) under both normal female rats (NL) and OS conditions. The cement-mediated bone augmentation observed in the NL spine was altered under OS conditions. CONCLUSIONS: This study suggests that cement bioreactivity is heightened and osteoconductivity may be limited in a preclinical model of the OS. The disparity between the two resorption profiles suggests that this accelerated cement resorption is a material-dependent phenomenon. The proinflammatory and pro-osteolytic bone environment associated with the osteoporosis disease state may contribute to the accelerated resorption and altered osteoconductivity exhibited by both materials. Future study of potential biomaterials intended for use within the OS may necessitate further exploration of the relationship between biomaterial performance and osteoporosis bone biology.